Electronic medical record documentation of germline genetic evaluations in patients with ovarian cancer
Journal of Genetic Counseling · 2024
DOI: 10.1002/jgc4.1731 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Genetic Counseling, 2024. Verfasst von Melissa Batson und 7 weiteren Autor:innen. Beteiligte Einrichtung: Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Electronic Health Records, Ovarian Neoplasms, Genetic Testing. Die Arbeit nennt 46 Literaturangaben.
Abstract (Originalsprache)
Germline genetic evaluation is indicated for all patients with epithelial ovarian cancer (EOC). For testing to have clinical utility, results must be documented within the electronic medical record (EMR) and accessible to providers at the point of care, which can be challenging in the context of current EMR limitations and genetic testing processes. We examined the receipt of genetics services and EMR capture of genetic testing results in patients with EOC. We conducted a retrospective chart review to examine germline genetic evaluations among patients with EOC seen by a gynecologic or medical oncologist at the University of Pennsylvania in 2016. EMRs were reviewed to determine: (1) if patients were referred for genetic evaluation; (2) if genetic testing was performed; (3) if results were documented in office notes, scanned third‐party test reports, and/or the EMR problem list; (4) if provider notes correctly listed the variant classification. Overall, 413 (62%) of patients had documented genetic testing. Genetic testing was documented in almost all provider notes (96%) and the majority of scanned EMR reports (64%). Pathogenic variants were found in 119 (29%) individuals; the majority (70%) had genetic testing documented within EMR problem lists. Provider notes were highly accurate in describing variant classification. In this study, genetic testing was performed and documented in the EMR for most EOC patients. Approximately one‐third of those tested did not have scanned test reports specifying variant found, limiting the utility of test results for cascade testing and therapeutic decisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Basser Center for BRCA at the Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Lindsay G Goldblatt, Payal D Shah
Zitieren
APA
Batson, M., Goldblatt, L. G., Pundock, S., Arutyunov, A., McKenna, D., Haggerty, A., Symecko, H., & Shah, P. D. (2024). Electronic medical record documentation of germline genetic evaluations in patients with ovarian cancer. Journal of Genetic Counseling. https://doi.org/10.1002/jgc4.1731
Vancouver
Batson M, Goldblatt LG, Pundock S, Arutyunov A, McKenna D, Haggerty A, et al. Electronic medical record documentation of germline genetic evaluations in patients with ovarian cancer. Journal of Genetic Counseling. 2024. doi:10.1002/jgc4.1731
BibTeX
@article{Batson2024,
author = {Batson, Melissa and Goldblatt, Lindsay G and Pundock, Stacy and Arutyunov, Anna and McKenna, Danielle and Haggerty, Ashley and Symecko, Heather and Shah, Payal D},
title = {Electronic medical record documentation of germline genetic evaluations in patients with ovarian cancer},
journal = {Journal of Genetic Counseling},
year = {2024},
doi = {10.1002/jgc4.1731}
}
EUVIMED